Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Johnson and Johnson
Cantor Fitzgerald

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,395,421

« Back to Dashboard

Summary for Patent: 4,395,421

Title: Disodium cromoglycate formulations
Abstract:There is described disodium cromoglycate in a form having a bulk density of greater than 0.45 g per ml when measured according to British Standard Test No 1460 (1967). There are also described granular and unit dosage forms of disodium cromoglycate. The disodium cromoglycate is useful, e.g. in the treatment of certain conditions of the gastrointestinal tract.
Inventor(s): Taylor; James E. (Loughborough, GB2), Stevenson; Neil A. (Loughborough, GB2)
Assignee: Fisons Limited (Ipswich, GB2)
Application Number:06/067,104
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,395,421

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom43054/76Oct 16, 1976

International Patent Family for Patent: 4,395,421

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2898377► Subscribe
Australia508134► Subscribe
Belgium858858► Subscribe
Canada1133830► Subscribe
Germany2741202► Subscribe
France2365565► Subscribe
United Kingdom1549229► Subscribe
Ireland45690► Subscribe
Israel52961► Subscribe
JapanH0137369► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Cantor Fitzgerald
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: